A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Genetic Technologies (NASDAQ:GENE) stock tumbled 26% in afternoon trading Thursday after the genomics-based test developer announced a $2M registered direct offering. Shares of Genetic Technologies ...

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has partnered with Stayhealthy, Inc. to distribute Stayhealthy’s Multi-Risk Test across North America, marking a ...

Genetic Technologies (NASDAQ:GENE) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from ...

It’s been 20 years since the Human Genome Project produced humanity’s genetic instruction manual and opened the door to a new kind of medicine that can precisely identify diseases and treatments.

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...

Jan. 14—ROCHESTER — Vyriad, a growing Rochester firm, recently raised an additional $25 million in funding to fuel its "race" to bring a new technology to market that accurately targets cancer within ...